Showing 101 - 120 results of 1,071 for search '"B cell"', query time: 0.13s Refine Results
  1. 101
  2. 102

    Cytotoxicity and Genotoxicity of Biogenic Silver Nanoparticles in A549 and BEAS-2B Cell Lines by Musthahimah Muhamad, Nurhidayah Ab.Rahim, Wan Adnan Wan Omar, Nik Nur Syazni Nik Mohamed Kamal

    Published 2022-01-01
    “…A significant cytotoxic effect was observed by AgNPs-GA on both A549 and BEAS-2B cell lines, with IC50 values of 20–28 μg/ml and 12–35 μg/ml, respectively. …”
    Get full text
    Article
  3. 103
  4. 104

    Neutrophil-Derived IL-6 Potentially Drives Ferroptosis Resistance in B Cells in Lupus Kidney by Zechen Wang, Jiajia Shen, Kun Ye, Jingjie Zhao, Shaoang Huang, Siyuan He, Yujuan Qin, Lingzhang Meng, Jie Wang, Jian Song

    Published 2023-01-01
    “…Ferroptosis resistance is vital for B cell development, especially in inflammatory diseases, yet the underlying mechanism is still unclear. …”
    Get full text
    Article
  5. 105

    Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma by Hui-Ju Hsieh, Ryan Urak, Mary C. Clark, Larry W. Kwak, Stephen J. Forman, Xiuli Wang

    Published 2025-03-01
    “…We found that ex vivo 0.25 μM capivasertib treatment during the period of T cell stimulation during manufacture enhanced the antitumor activity of CAR T cells in B cell lymphoma mouse models. Mechanistically, capivasertib changed gene and protein expression patterns related to the functions of memory and effector CAR T cells. …”
    Get full text
    Article
  6. 106

    Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels by Ruonan Shao, Danchen Meng, Beibei Gao, Lu Zhang, Qingqi Meng, Yanqiu Hou, Zhangbiao Long, Jinsong Yan, Xiaofeng Shi

    Published 2025-01-01
    “…Abstract It has been documented that D-dimer levels have potential utility as a measure of tumor activity in diffuse large B-cell lymphoma (DLBCL), however whether it can be used as a predictive marker of treatment outcome has not been established. …”
    Get full text
    Article
  7. 107

    A Rare Case of ALK-Positive Large B-Cell Lymphoma with CD33 Expression by Jessica Corean, K. David Li

    Published 2018-01-01
    “…Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK+ LBCL) is a very rare and aggressive subtype of diffuse large B-cell lymphoma characterized by ALK rearrangement. …”
    Get full text
    Article
  8. 108

    Mediastinal B-Cell Lymphoma Presenting with Jugular-Subclavian Deep Vein Thrombosis as the First Presentation by Sherif Ali Eltawansy, Mana Rao, Sidney Ceniza, David Sharon

    Published 2015-01-01
    “…Jugular venous thrombosis infrequently could be secondary to malignancy and has seldom been reported secondary to mediastinal large B-cell lymphomas. The postulated mechanisms are mechanical compression that leads to stagnation of blood in the venous system of the neck and/or an increase in the circulating thrombogenic elements that could cause venous thromboembolism as a paraneoplastic phenomenon. …”
    Get full text
    Article
  9. 109

    Short-Chain Fatty Acids Promote Immunotherapy by Modulating Immune Regulatory Property in B Cells by Cai-Jie Zhou, Bai-Ling Xie, Hai-Yang Han, Yin Wang, Yong-Hua Wang, Jing-Yi Hong, Yi-Xia Wei, Zhi-Gang Liu, Yan Feng, Gui Yang, Ping-Chang Yang

    Published 2021-01-01
    “…The dysfunction of regulatory B cells (Breg) may result in immune inflammation such as allergic rhinitis (AR); the underlying mechanism is not fully understood yet. …”
    Get full text
    Article
  10. 110
  11. 111

    CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type by Alexandra Papoudou-Bai, Leonidas Marinos, Amalia Vassou, Eleni Kapsali, Panagiotis Kanavaros

    Published 2019-01-01
    “…Most primary cutaneous B-cell lymphomas (PCBCL) are CD5 negative, and only a few cases were found to express CD5. …”
    Get full text
    Article
  12. 112
  13. 113

    Synchronous Diagnosis of Multiple Myeloma, Breast Cancer, and Monoclonal B-Cell Lymphocytosis on Initial Presentation by A. Vennepureddy, V. Motilal Nehru, Y. Liu, F. Mohammad, J. P. Atallah

    Published 2016-01-01
    “…Here we report an unusual case of concomitant existence of multiple myeloma, breast cancer, and monoclonal B-cell lymphocytosis on initial presentation. The challenge was to accurately diagnose each disease and stage in order to maximize the therapeutic regimen to achieve cure/remission. …”
    Get full text
    Article
  14. 114

    Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells by Marieke C. H. Hogenes, Suzanne van Dorp, Joyce van Kuik, Filipa R. P. Monteiro, Natalie ter Hoeve, Liane Guedes, Marijke R. van Dijk, Anton C. Martens, Roel A. de Weger

    Published 2019-01-01
    “…With (early) B-cell depletion using Rituximab, a clear improvement on clinical symptoms was observed, even when probably only inactivated B-cells were deleted. …”
    Get full text
    Article
  15. 115

    Primary splenic diffuse large B-cell lymphoma presenting with a gastrosplenic fistula: Case report by Hurerah Nawaz, Josh Greaser, Irfan Amir Kazi, Ayesha Nasrullah

    Published 2025-03-01
    “…Primary splenic diffuse large B-cell lymphoma (PS-DLBCL) is a rare manifestation of malignant lymphoma. …”
    Get full text
    Article
  16. 116

    Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps by Fang Zhang, Zhenhang Xu, Xi He, Yi Sun, Chong Zhao, Jianhui Zhang

    Published 2022-01-01
    “…This study is aimed at exploring the expression of B cell-activating factor (BAFF) in CRSwNP and its association with postoperative recurrence. …”
    Get full text
    Article
  17. 117
  18. 118

    Severe Lactic Acidosis in a Patient with B-Cell Lymphoma: A Case Report and Review of the Literature by Farn Huei Chan, Daniel Carl, Laurel J. Lyckholm

    Published 2009-01-01
    “…We present a case of a 59-year-old female with lactic acidosis who was found to have aggressive B-cell lymphoma. There have been 29 cases of lymphoma induced lactic acidosis reported thus far; however all reported cases have abnormal vital signs or concomitant medical conditions that may lead to lactic acidosis. …”
    Get full text
    Article
  19. 119

    Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry by Frederick L Locke, Grant Schofield, Marcelo Pasquini, Matthew J Frigault, Cameron J Turtle, Stephen Lim, Brian Hill, Samantha Jaglowski, Caron A Jacobson, Gunjan Shah, Daniel J Landsburg, Michael Heim, Stephen Ronan Foley, Ron Ram, Peter A Riedell, Leslie L Popplewell, Ranjan Tiwari, Marta Majdan, Aisha Masood

    Published 2025-02-01
    “…Background Tisagenlecleucel, a CD19 chimeric antigen receptor T-cell therapy, is approved for adults with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBCL) after ≥2 lines of therapy. …”
    Get full text
    Article
  20. 120

    Disseminated nocardiosis in a patient with AIDS and B-cell non-Hodgkin’s lymphoma: a case report by Delvis R. Reverón, David M. Flora-Noda, Lily M. Soto, Maribel Dolande, Juan Frey, Aleiram Chaurio, Bárbara D. Ruiz-Alayón, Jocays Caldera, Fhabián S. Carrión-Nessi, David A. Forero-Peña

    Published 2025-01-01
    “…Post-mortem biopsy and immunohistochemistry identified non-Hodgkin’s lymphoma of B-cell lineage, and mycological culture of BM isolated Nocardia farcinica. …”
    Get full text
    Article